Invista has been granted a patent for bio-derived raw materials technology from the US Patent and Trademark Office for work it has done with synthetic biology specialist Arzeda.

The patent is for engineered polypeptides and their related crystal structure details, which are useful for producing bio-derived compounds such as butadiene and isoprene.

“The work detailed in this patent provides innovative solutions to potentially increase the global supply of bio-derived chemicals,” said Bill Greenfield, president of Invista’s Intermediates business. “This patent demonstrates our commitment to developing new bio-derived processes for a range of products.”

Share this story: